ALLMedicine™ Esophageal Cancer Center

Jun 26th, 2022 - Recent research indicates long-term survival benefits of minimally invasive esophagectomy (MIE) compared with open esophagectomy (OE) for patients with esophageal and gastroesophageal junction (GEJ) cancers, but there is a need for more population...

Jun 26th, 2022 - Patients with oral cancer are at higher risk of developing second primary esophageal cancer (SPEC) and the consensus for screening strategies remains unclear. This study aimed to examine comparative effectiveness and the stage-shift effect of endo...

Jun 25th, 2022 - Esophageal cancer (EC), a common malignant tumor of digestive tract, is also one of the most deadly cancers. Accumulating studies have shown that the initiating and progressing multiple human diseases were closely related to the expression of MAIP...

Jun 25th, 2022 - To establish and validate a contrast-enhanced computed tomography-based hybrid radiomics nomogram for prediction of local recurrence-free survival (LRFS) in esophageal squamous cell cancer (ESCC) patients receiving definitive (chemo)radiotherapy i...

Jun 24th, 2022 - Two large, nutritional intervention trials were conducted in Linxian, China between 1985-1991. These trials tested the effect of multiple vitamins and minerals in the prevention of esophageal cancer in a population with the highest known rate for ...

May 28th, 2022 - Gastric, esophageal and gastro-esophageal junction cancers are associated with inferior outcomes. For early-stage disease, perioperative chemotherapy or chemoradiation followed by surgery is the standard treatment. For most patients with advanced ...

Jun 23rd, 2020 - To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with locally advanced esophageal cancer. ASCO convened an Expert Panel to conduct a systematic review of the more recently published litera...

Sep 2nd, 2018 -

Mar 1st, 2017 - The epidemic of obesity continues at alarming rates, with a high burden to our economy and society. The American Gastroenterological Association understands the importance of embracing obesity as a chronic, relapsing disease and supports a multidi...

Dec 3rd, 2016 - We report analytic and consensus processes that produced recommendations for neoadjuvant pathologic stage groups (ypTNM) of esophageal and esophagogastric junction cancer for the AJCC/UICC cancer staging manuals, 8th edition. The Worldwide Esophag...

Jun 24th, 2022 - Two large, nutritional intervention trials were conducted in Linxian, China between 1985-1991. These trials tested the effect of multiple vitamins and minerals in the prevention of esophageal cancer in a population with the highest known rate for ...

Jun 24th, 2022 - Esophageal squamous cell carcinoma (ESCC) is a major cause of death in the central Asian esophageal cancer belt and human papillomavirus (HPV) has been proposed as a potential cause. While several HPV-associated cancers have been identified (e.g.,...

Jun 24th, 2022 - The overall goal of this project is to understand the role of genetics in the etiology and prevention of upper gastrointestinal cancer, primarily esophageal cancer, but also cancers of the gastric cardia and body. Esophageal cancer is the fourth m...

Jun 24th, 2022 - Esophageal cancer is the sixth most common cause of cancer death worldwide, killing over 380,000 people each year. Over 80% of esophageal cancers occur in developing countries, where the great majority of cases are squamous cell carcinomas. Esopha...

Jun 22nd, 2022 - The primary objective of this study is to evaluate the efficacy of OncoGel given in combination with standard chemotherapy (cisplatin and 5-FU) and radiation therapy in patients with previously untreated, resectable, local or local-regional adenos...

Jun 7th, 2022 - Endoscopic screening for esophageal adenocarcinoma (EAC), may not be a cost-effective strategy for all populations, possibly even leading to net harm in some, according to a comparative cost-effectiveness analysis. Several U.

May 30th, 2022 - Immunotherapy with nivolumab (Opdivo) is now approved in the United States for first-line use in the treatment of unresectable advanced or metastatic esophageal squamous cell carcinoma (ESCC). The new approval for the drug, a programmed cell death...

May 24th, 2022 - NEW YORK (Reuters Health) - Delays in surgery for advanced esophageal cancer, such as those implemented in the first months of the COVID-19 pandemic, result in significantly worse outcomes, a new analysis found. Delayed surgery did not appear to a...

May 18th, 2022 - NEW YORK (Reuters Health) - Researchers have developed and validated a liquid biopsy assay that can predict response to neoadjuvant therapy (NAT) in patients with esophageal squamous-cell carcinoma (ESCC), which may lead to more-personalized treat...

May 16th, 2022 - An alarming increase in both esophageal cancer (EC) and the primary precursor lesion for esophageal adenocarcinoma known as Barrett's esophagus (BE) has been observed among middle-aged adults over the past 5 years, and it's not due to better or mo...